Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Ovarian Neoplasms 28Small Cell Lung Carcinoma 26Lung Neoplasms 20Neuroblastoma 17Carcinoma, Ovarian Epithelial 17Fallopian Tube Neoplasms 12Brain Neoplasms 10Uterine Cervical Neoplasms 8Sarcoma 8Leukemia 8Leukemia, Myeloid, Acute 6Central Nervous System Neoplasms 6Recurrence 5Medulloblastoma 5Lymphoma 5Gliosarcoma 5Glioblastoma 5Sarcoma, Ewing 4Rhabdoid Tumor 4Retinoblastoma 4Osteosarcoma 4Neuroectodermal Tumors, Primitive, Peripheral 4Neoplasms 4Burkitt Lymphoma 4Wilms Tumor 3Neoplasm Metastasis 3Myelodysplastic Syndromes 3Lymphoma, Non-Hodgkin 3Lymphoma, Large B-Cell, Diffuse 3Glioma 3

Interventions

Cyclophosphamide 33fludarabine phosphate 19Peripheral Blood Stem Cell Transplantation 19Mycophenolic Acid 17Whole-Body Irradiation 15Etoposide 15Rituximab 14Tacrolimus 13Busulfan 12Vincristine 11Prednisone 11Methotrexate 11Filgrastim 11Doxorubicin 11Cyclosporine 11Radiotherapy 10Brentuximab Vedotin 10Antilymphocyte Serum 10Methylprednisolone 8Cytarabine 8Melphalan 7Cisplatin 6Ifosfamide 5Gemcitabine 5merphos 4ibritumomab tiuxetan 4Sirolimus 4Flow Cytometry 4Dexamethasone 4Cyclosporins 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Lymphoma, Large-Cell, Anaplastic × Topotecan × Clear all
NCT00006125 2016-07-14

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma

Alliance for Clinical Trials in Oncology

Phase 2 Completed
Lymphoid

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡